📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Unlocking Personalized Biomedicine and Drug Discovery with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Fit for Purpose or Forever Elusive? (2020)

First Author: De Korte T

Attributed to: BHF Imperial Cardiovascular Regenerative Medicine Centre funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1146/annurev-pharmtox-010919-023309

PubMed Identifier: 31506008

Publication URI: http://europepmc.org/abstract/MED/31506008

Type: Journal Article/Review

Volume: 60

Parent Publication: Annual review of pharmacology and toxicology

ISSN: 0362-1642